Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Conditions

Study of Risk Factors for IPMNs Degeneration at the Nancy CHRU 1

Interventions

Surveys and Questionnaires 529 Blood Specimen Collection 406 Surgical Procedures, Operative 151 Radiotherapy 131 Interviews as Topic 131 Drug Therapy 123 Observation 122 Magnetic Resonance Spectroscopy 104 Biopsy 103 Specimen Handling 70 Data Collection 70 Neoadjuvant Therapy 65 Immunohistochemistry 64 Magnetic Resonance Imaging 61 Immune Checkpoint Inhibitors 59 Watchful Waiting 52 Immunotherapy 51 Bevacizumab 50 Positron Emission Tomography Computed Tomography 46 Ultrasonography 44 Hematologic Tests 42 Liquid Biopsy 41 Tomography, X-Ray Computed 40 Therapeutics 40 Radiosurgery 40 Colonoscopy 40 pembrolizumab 37 Hepatectomy 37 Gene Expression Profiling 36 High-Energy Shock Waves 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Observational × Sensitivity and Specificity × Clear all

NCT04901364 2021-05-25

IPMN

Central Hospital, Nancy, France

Study of Risk Factors for IPMNs Degeneration at the Nancy CHRU

Data powered by HemOnc (CC BY 4.0) Colophon ⚡